v3.26.1
SHARE-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Stock Option Activity
The following table summarizes stock option activity during the six months ended June 30, 2026:
Weighted Average
Shares Underlying Options
Exercise
Price
Remaining Contractual Term (years)
Aggregate
Intrinsic Value
(in thousands)
Outstanding at December 31, 20258,241,429 $19.91 5.89$150,796 
Granted1,353,230 $33.97 
Exercised(1,575,054)$20.68 $32,560 
Forfeited/canceled(73,441)$22.15 
Outstanding at June 30, 20267,946,164 $22.13 6.55$275,548 
Vested and expected to vest at June 30, 20267,946,164 $22.13 6.55$275,548 
Exercisable at June 30, 20265,156,156 $20.56 5.32$186,921 
Schedule of Service Based Restricted Stock Activity
The following table summarizes the Company’s service based restricted stock unit activity during the six months ended June 30, 2026:
Number of Restricted Stock UnitsWeighted Average Grant Date Fair Value
Unvested at December 31, 20254,567,367 $18.02 
Granted2,326,360 $33.50 
Vested(1,368,563)$18.21 
Forfeited/canceled(180,880)$22.79 
Unvested at June 30, 20265,344,284 $24.55 
Schedule of Performance Based Restricted Stock Activity
The following table summarizes the Company’s performance based restricted stock unit activity during the six months ended June 30, 2026:
Number of Restricted Stock UnitsWeighted Average Grant Date Fair Value
Unvested at December 31, 2025233,604 $16.35 
Granted215,730 $24.94 
Vested(229,500)17.77 
Forfeited/canceled— — 
Unvested at June 30, 2026219,834 $23.30 
Schedule of Share Based Compensation Expenses
The following table sets forth share-based compensation for continuing operations for the three and six months ended June 30, 2026 and 2025 (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Research and development$6,873 $3,990 $12,431 $8,716 
Selling, general and administrative14,915 6,659 25,503 13,425 
Total share-based compensation$21,788 $10,649 $37,934 $22,141